Physician profile
Jorge Pando
NPI 1437323219
$2,870.24
in general payments reported to CMS, 2019-2025
18 companies · $144 in 2025
The $144 reported for 2025 was more than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $289 · 2020: $236 · 2021: $703 · 2022: $529 · 2023: $909 · 2024: $59.99 · 2025: $144.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,100 · Education: $13.35.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,099.56 |
| Education | $13.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $939.86 | 2021-2025 | |
| Astellas Pharma US INC | $863.58 | 2019-2025 | Veozah, Myrbetriq |
| Abbvie INC. | $266.54 | 2020-2025 | |
| Conmed Corporation | $232.86 | 2021-2023 | Airseal |
| Pfizer INC. | $154.65 | 2019-2023 | |
| Sumitomo Pharma America, INC. | $121.58 | 2023-2025 | Gemtesa, Myfembree |
| Caldera Medical, INC | $68.40 | 2021 | |
| Coloplast Corp | $32.74 | 2019-2021 | |
| Axonics, INC. | $29.15 | 2022 | |
| Hologic Sales and Service, LLC | $26.95 | 2024 | Thinprep 2000 Processor, Aptima |
| Davol INC. | $26.40 | 2019 | |
| Avion Pharmaceuticals | $23.45 | 2022 | |
| Evofem Biosciences, INC. | $21.18 | 2025 | Phexxi, Phexx, Solosec |
| Exeltis, USA INC. | $19.69 | 2024 | Slynd |
| Coopersurgical, INC. | $17.06 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Millicent US INC | $13.35 | 2024 | |
| Urovant Sciences INC | $12.80 | 2022 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jorge Pando listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.